The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Novartis
Consulting or Advisory Role - AstraZeneca
Speakers' Bureau - Novartis

Clinical value of timely targeted therapy (TT) for patients with advanced non-small cell lung cancer (aNSCLC) with actionable driver oncogenes (ADO).
 
Thomas Stricker
Employment - Tennessee Oncology/OneOncology
Honoraria - Illumina
 
Neha Jain
No Relationships to Disclose
 
Elaine Yu
Employment - Genentech/Roche
Stock and Other Ownership Interests - Roche
Research Funding - Genentech/Roche (Inst)
Patents, Royalties, Other Intellectual Property - Listed as inventor on a pending patent application for Display screen with icon or graphical user interface
Travel, Accommodations, Expenses - Genentech/Roche
 
Esprit Ma
Employment - Genentech
Stock and Other Ownership Interests - Genentech
 
Robert Schuldt
Employment - Genentech
Stock and Other Ownership Interests - Genentech/Roche; UnitedHealthcare
Travel, Accommodations, Expenses - Genentech
 
Rongrong Wang
Employment - Genentech
Stock and Other Ownership Interests - Roche
 
Jesse Sussell
Employment - Genentech
Stock and Other Ownership Interests - Roche
 
Sarika Ogale
Employment - Genentech
Stock and Other Ownership Interests - Roche
 
Tania Szado
Employment - Genentech
Stock and Other Ownership Interests - Genentech/Roche; Moderna Therapeutics
 
Richard Price
Employment - Genentech/Roche
Stock and Other Ownership Interests - Genentech/Roche
Patents, Royalties, Other Intellectual Property - Healthcare technology patent (I)
 
Victor T. G. Lin
Stock and Other Ownership Interests - Agilent; AstraZeneca; Bristol Myers Squibb; Novartis
Research Funding - BeiGene; Merck; Mirati Therapeutics; Pfizer; Regeneron
 
Dennis Slater
No Relationships to Disclose
 
Daniel A. Vaena
Honoraria - HMP; OncLive; OneOncology
Consulting or Advisory Role - AVEO; Bayer; Bristol-Myers Squibb; Eisai; EMD Serono; Exelixis; Immunomedics; Seagen
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Compugen (Inst); Exelixis (Inst); Merck (Inst); OBI Pharma (Inst); Roche/Genentech (Inst); Seagen (Inst); Tizona Therapeutics, Inc. (Inst)
Travel, Accommodations, Expenses - Caris Life Sciences; Tempus
 
Harry Staszewski
No Relationships to Disclose
 
Bruno Fang
Employment - Astera Cancer Care
Leadership - Astera Cancer Care
Research Funding - Abbvie; Arvinas; Bristol-Myers Squibb/Pfizer; Daiichi Sankyo/Astra Zeneca; Epizyme; Exelixis; Gilead/Forty Seven; ImmunityBio; Janssen Oncology; Mirati Therapeutics; natera; Novartis; Novocure; POINT Biopharma; Roche/Genentech; Veru; Zymeworks; Zymeworks
 
Lasika Seneviratne
No Relationships to Disclose
 
Edward Arrowsmith
Employment - Tennessee Oncology
Stock and Other Ownership Interests - OneOncology
Consulting or Advisory Role - Flatiron Health
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Calistoga Pharmaceuticals (Inst); Celgene (Inst); Cephalon (Inst); Chorus (Inst); Clovis Oncology (Inst); Cougar Biotechnology (Inst); Eisai (Inst); EMD Serono (Inst); Evelo Biosciences (Inst); Exelixis (Inst); Genentech (Inst); Gilead Sciences (Inst); Incyte (Inst); Infinity Pharmaceuticals (Inst); Janssen Research & Development (Inst); Lilly (Inst); Merck (Inst); Millennium (Inst); Modra Pharmaceuticals (Inst); Novartis (Inst); Oncogenex (Inst); Onyx (Inst); Peloton Therapeutics (Inst); Pfizer (Inst); Sarah Cannon Research Institute (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Flatiron Health; OneOncology
Other Relationship - Sarah Cannon Research Institute (Inst)
 
Davey B. Daniel
Employment - OneOncology
Leadership - OneOncology
Speakers' Bureau - HMP; IDEOlogy Health
Research Funding - Abbvie (Inst); Amgen (Inst); ARMO BioSciences (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Daiichi Sankyo (Inst); EQRx (Inst); G1 Therapeutics (Inst); G1 Therapeutics (Inst); Genentech (Inst); Genentech (Inst); Genentech (Inst); Genentech (Inst); Genentech (Inst); Guardant Health (Inst); Immunomedics (Inst); Janssen Research & Development (Inst); Lilly (Inst); Merck (Inst); Merus NV (Inst); Novartis (Inst); Novartis (Inst); Roche (Inst); Roche (Inst); Roche (Inst)